$400 million in compensation! By Ranbaxy get a body of coquettish first three altogether finally get comfort!

Source: medicine magic cube 2016-05-11 the first three obtained 54.8% equity of Ranbaxy company, the largest pharmaceutical company in India at that time, at the cost of US $4.6 billion in 2008, including 34.8% equity purchased directly from malvinder Mohan Singh, founder and CEO of Ranbaxy company and his family for us $2.4 billion But the vision of a strong alliance between the two companies has not been realized Ranbaxy faced seven felony charges related to the production of substandard drugs (lack of active ingredients) in early 2013, and the first three parties eventually had to pay $500 million to reach a settlement with the U.S government Later, more prosecutors reported to the FDA that Ranbaxy deliberately falsified drug test data and used qualified drugs to cope with FDA inspection The FDA then tormented two of Ranbaxy's factories and banned its products from exporting to the United States The intolerable first three Communist Party then submitted a complaint to the international arbitration court against malvinder Mohan Singh and his younger brother, shivinder Mohan Singh, saying that they were maliciously deceived and fell into a crisis of extremely chaotic management and goodwill, resulting in huge investment losses At the same time, the first three parties are also eager to get rid of the hot potato of Ranbaxy In April 2014, they reached an agreement with another Indian pharmaceutical company, sunpharma, to sell their shares of Ranbaxy to the other party in the form of 4 billion US dollars full stock transaction, and at the same time, they asked sunpharma to be responsible for the quality problems of Ranbaxy since then, so as to get clean Singapore's arbitration court recently announced its support for the demands of the first and third parties, and awarded malvinder Mohan Singh family compensation of 400 million US dollars, which was a little consolation to the first and third parties.